Divalproex Sodium Tablet, Delayed Release shortage
To Be DiscontinuedDivalproex Sodium Tablet, Delayed Release is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.
Therapeutic category
Dosage form
Tablet
Routes
ORAL
Last updated
04/28/2025
Strength variants
- Not specified
Need sourcing help for Divalproex Sodium Tablet, Delayed Release?
Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.
Connect with a sourcing partnerManufacturers reporting shortage
- Upsher-Smith Laboratories, LLC800-654-2299To Be Discontinued
- Upsher-Smith Laboratories, LLC800-654-2299To Be Discontinued
- Upsher-Smith Laboratories, LLC800-654-2299To Be Discontinued
- Upsher-Smith Laboratories, LLC800-654-2299To Be Discontinued
- Upsher-Smith Laboratories, LLC800-654-2299To Be Discontinued
- Upsher-Smith Laboratories, LLC800-654-2299To Be Discontinued
- Upsher-Smith Laboratories, LLC800-654-2299To Be Discontinued
- Upsher-Smith Laboratories, LLC800-654-2299To Be Discontinued
Reason for shortage
ad slot 300x250
Related shortages in Neurology
Lorazepam Injection
- Category
- Neurology
- Reason
- Demand increase for the drug
- Updated
- 04/02/2026
Valproate Sodium Injection
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/02/2026
Lorazepam Injection
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/02/2026
Riluzole Oral Suspension
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/01/2026
Clonazepam Tablet
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/01/2026
Clonazepam Tablet
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/01/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.